Enteric coated risedronate 35mg for the treatment of osteoporosis

Description

In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Jacob George

Prof Jacob George

Fatty Liver, CV Risk, and Post-Menopause

Prof Sebastian King

Prof Sebastian King

Paediatric Constipation & Related Issues

Hayley Ryan

Hayley Ryan

Management of Skin Tear in General Practice

Dr Katherine Spira

Dr Katherine Spira

Migraine vs Chronic Daily Headache

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Ego Seeman

expert

Prof Ego Seeman

Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis

Date published: 7 November 2023